SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-195750
Filing Date
2019-07-17
Accepted
2019-07-17 17:24:02
Documents
1
Group Members
CLAY B. THORPDOUGLAS REEDHATTERAS NC FUND, LPHATTERAS VENTURE ADVISORS IV SBIC, LLCHATTERAS VENTURE ADVISORS IV, LLCHATTERAS VENTURE AFFILIATES III, LPHATTERAS VENTURE PARTNERS III, LPHATTERAS VENTURE PARTNERS IV SBIC, LPHATTERAS VENTURE PARTNERS IV, LPJO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d777954dsc13da.htm SC 13D/A 233335
  Complete submission text file 0001193125-19-195750.txt   235356
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89527 | Film No.: 19959801
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 S. MANGUM STREET, SUITE 350 DURHAM NC 27701
Business Address 280 S. MANGUM STREET, SUITE 350 DURHAM NC 27701 919-484-0730
Hatteras Venture Advisors III, LLC (Filed by) CIK: 0001674177 (see all company filings)

IRS No.: 204822068 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13D/A